Page last updated: 2024-09-04

beta-lactams and Skin Diseases

beta-lactams has been researched along with Skin Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chakkavittumrong, P; Chanprapaph, K; Chularojanamontri, L; Disphanurat, W; Klaewsongkram, J; Rerknimitr, P; Rerkpattanapipat, T; Srinoulprasert, Y; Srisuttiyakorn, C; Sukasem, C; Suthumchai, N; Thantiworasit, P; Tovanabutra, N; Tuchinda, P1
Broekhuizen, BD; Rockmann, H; Salden, OA; Verheij, TJ1
Gesser, RM; McCarroll, KA; Woods, GL1
Ceesay, TP; Gesser, R; Graham, DR; Holtom, P; Lucasti, C; Malafaia, O; McAdams, A; Nichols, RL; Perez, NQ; Woods, GL1

Trials

2 trial(s) available for beta-lactams and Skin Diseases

ArticleYear
Evaluation of outpatient treatment with ertapenem in a double blind controlled clinical trial of complicated skin/skin structure infections.
    The Journal of infection, 2004, Volume: 48, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Ertapenem; Female; Humans; Infusions, Intravenous; Lactams; Logistic Models; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Skin Diseases; Statistics, Nonparametric; Tazobactam; Treatment Outcome

2004
Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, double-blind multicenter study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Jun-01, Volume: 34, Issue:11

    Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Ertapenem; Female; Humans; Lactams; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Pseudomonas aeruginosa; Skin Diseases; Staphylococcus aureus; Tazobactam; Treatment Outcome

2002

Other Studies

2 other study(ies) available for beta-lactams and Skin Diseases

ArticleYear
Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs.
    The journal of allergy and clinical immunology. In practice, 2019, Volume: 7, Issue:1

    Topics: Adult; Aged; Alleles; Allopurinol; Anticonvulsants; beta-Lactams; Cells, Cultured; Drug Hypersensitivity; Drug Hypersensitivity Syndrome; Drug-Related Side Effects and Adverse Reactions; Enzyme-Linked Immunospot Assay; Female; Genetic Association Studies; Genotype; HLA-B Antigens; Humans; Interferon-gamma; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Polymorphism, Genetic; Skin Diseases; Thailand

2019
Diagnosis of allergy against beta-lactams in primary care: prevalence and diagnostic criteria.
    Family practice, 2015, Volume: 32, Issue:3

    Topics: Adolescent; Adult; Age Distribution; Anti-Bacterial Agents; Asthma; beta-Lactams; Child; Child, Preschool; Comorbidity; Diagnostic Errors; Drug Hypersensitivity; Electronic Health Records; Female; Humans; Immune System Diseases; Infant; Infant, Newborn; Male; Middle Aged; Netherlands; Prevalence; Primary Health Care; Registries; Retrospective Studies; Sex Distribution; Skin Diseases; Young Adult

2015